OpenDNA
Nir Gamliel is the Chief Business Officer at OpenDNA, a company that focuses on utilizing a cloud-based precision medicine AI platform to predict and treat complex polygenic diseases. Prior to this role, Nir served as the President and CEO at PharBeyond, a business development company in the pharmaceutical, biotechnology, and medical device fields. Nir also held positions at TikTalk, BiolineRx, BSP Biological Signal Processing, Compugen Ltd., Voltaire, and Johnson & Johnson throughout their career. Nir obtained a B.Sc. in Biology from Bar-Ilan University.
This person is not in any teams
This person is not in any offices
OpenDNA
OpenDNA has created a cloud based precision genomic medicine platform for cardiovascular disease and diabetes that uses AI algorithms to predict risk and provide personalized treatments to patients. We believe the future of medicine is using data to improve patient outcomes and to reduce healthcare costs